High Dose Ifosfamide in Relapsed and Unresectable High-Grade Osteosarcoma Patients: A Retrospective Series

High Dose Ifosfamide in Relapsed and Unresectable High-Grade Osteosarcoma Patients: A Retrospective Series

<i>Background</i>: The evidence on high-dose ifosfamide (HD-IFO) use in patients with relapsed osteosarcoma is limited. We performed a retrospective study to analyze HD-IFO activity. <i>Methods</i>: Patients with osteosarcoma relapsed after standard treatment [methotrexate, d...

Full description

Bibliographic Details
Main Authors:	Emanuela Palmerini, Elisabetta Setola, Giovanni Grignani, Lorenzo D’Ambrosio, Alessandro Comandone, Alberto Righi, Alessandra Longhi, Marilena Cesari, Anna Paioli, Rossella Hakim, Michela Pierini, Emanuela Marchesi, Daniel Vanel, Ymera Pignochino, Davide Maria Donati, Piero Picci, Stefano Ferrari
Format:	Article
Language:	English
Published:	MDPI AG 2020-10-01
Series:	Cells
Subjects:	osteosarcoma high-grade bone sarcoma pediatric bone tumors ifosfamide chemotherapy PARP1
Online Access:	https://www.mdpi.com/2073-4409/9/11/2389

Similar Items

De l’ifosfamide au géranyloxy-ifosfamide : pharmacomodulation pour cibler et moduler l’immunité
by: Delahousse, Julia
Published: (2019)

Continuous 14 Day Infusional Ifosfamide for Management of Soft-Tissue and Bone Sarcoma: A Single Centre Retrospective Cohort Analysis
by: Thomas J. Carter, et al.
Published: (2020-11-01)

Ifosfamide-Induced Fanconi's Syndrome
by: Lin-Kun Lee, et al.
Published: (2014-06-01)

Neuropsychiatric Toxicity of Ifosfamide in Patients Admitted for Chemotherapy
by: Mohammadali Mashhadi, et al.
Published: (2010-03-01)

Neuropsychiatric Toxicity of Ifosfamide in Patients Admitted for Chemotherapy
by: Mohammadali Mashhadi, et al.
Published: (2010-01-01)

Renal side effects of Ifosfamide in patients admitted for chemotherapy
by: Mohammad Ali Mashhadi
Published: (2008-10-01)

Safe decontamination of cytostatics from the nitrogen mustards family. Part one: cyclophosphamide and ifosfamide
by: Štenglová Netíková IR, et al.
Published: (2018-11-01)

Recurrent Hepatic Sarcomatoid Carcinoma Cured by Doxorubicin and Ifosfamide Chemotherapy
by: Ming-En Lin, et al.
Published: (2015-09-01)

Lycopene restores liver function and morphology of ifosfamide-intoxicated rats
by: Elias Adikwu, et al.
Published: (2019-01-01)

Ifosfamide-induced Encephalopathy in Patients With Uterine Sarcoma
by: Shih-Hung Tsai
Published: (2010-03-01)

Two Cases of Fatal Encephalopathy Related to Ifosfamide: An Adverse Role of Aprepitant
by: Alice Séjourné, et al.
Published: (2014-09-01)

Interleukin-11 attenuates ifosfamide-induced hemorrhagic cystitis
by: Jose M. Mota, et al.
Published: (2007-10-01)

Lycopene abrogates ifosfamide-induced fanconi syndrome in albino rats
by: Elias Adikwu, et al.
Published: (2021-01-01)

Combined Chemotherapy with Vinorelbine and Ifosfamide as Third-line Treatment and Beyond of Advanced Non-small Cell Lung Cancer
by: Yang ZHOU, et al.
Published: (2015-06-01)

The Nephrotoxic Ifosfamide-Metabolite Chloroacetaldehyde Interferes with Renal Extracellular Matrix Homeostasis
by: Andreas Benesic, et al.
Published: (2014-04-01)

Osteopontin and fatty acid binding protein in ifosfamide-treated rats
by: Dobrek Łukasz, et al.
Published: (2019-07-01)

The efficacy and safety comparison of first-line chemotherapeutic agents (high-dose methotrexate, doxorubicin, cisplatin, and ifosfamide) for osteosarcoma: a network meta-analysis
by: Bin Zhang, et al.
Published: (2020-02-01)

Ifosfamide/cyclofosfamide-induced methemoglobinemia in pediatric patients with hemoblastoses
by: Timur T. Valiev, et al.
Published: (2021-02-01)

Efficacy of combination-chemotherapy with pirarubicin, ifosfamide, and etoposide for soft tissue sarcoma: a single-institution retrospective analysis
by: Shiro Saito, et al.
Published: (2020-09-01)

Gemcitabina e ifosfamida no tratamento do linfoma de Hodgkin refratário ou recidivado após múltiplas terapias Gemcitabine and ifosfamide in the treatment of Hodgkin's lymphoma refractory to or relapsed after multiple therapies
by: Luís Fernando Pracchia, et al.
Published: (2007-12-01)

Risk factors of ifosfamide-related encephalopathy in adult patients with cancer: A retrospective analysis
by: Yin Lo, et al.
Published: (2016-09-01)

Occupational exposure to antineoplastic drugs in hospital environments: potential risk associated with contact with cyclophosphamide- and ifosfamide-contaminated surfaces
by: Nicola Mucci, et al.
Published: (2020-09-01)

Quantitation of anticancer drugs – Cyclophosphamide and ifosfamide in urine and water sewage samples by gas chromatography–mass spectrometry
by: Veeravan Lekskulchai
Published: (2016-10-01)

Comparison of Ifosfamide, Carboplatin and Etoposide versus Etoposide, Steroid, and Cytarabine Cisplatin as Salvage Chemotherapy in Patients with Refractory or Relapsed Hodgkin's lymphoma
by: Valiollah Mehrzad, et al.
Published: (2017-01-01)

Chloroacétaldéhyde : de l’implication dans les mécanismes physiopathologiques de la néphrotoxicité de l’ifosfamide à la contribution à son effet anticancéreux
by: Knouzy, Burhan
Published: (2009)

Bladder urotoxicity pathophysiology induced by the oxazaphosphorine alkylating agents and its chemoprevention
by: Łukasz Dobrek, et al.
Published: (2012-09-01)

Ten-year follow-up results of perioperative chemotherapy with doxorubicin and ifosfamide for high-grade soft-tissue sarcoma of the extremities: Japan Clinical Oncology Group study JCOG0304
by: Kazuhiro Tanaka, et al.
Published: (2019-09-01)

PARP1 expression drives the synergistic antitumor activity of trabectedin and PARP1 inhibitors in sarcoma preclinical models
by: Ymera Pignochino, et al.
Published: (2017-04-01)

Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab
by: Emanuela Palmerini, et al.
Published: (2021-01-01)

Paclitaxel, Ifosfamide, and Cisplatin in Patients with Poor-prognosis Disseminated Nonseminomatous Germ Cell Tumors with Unfavorable Serum Tumor Marker Decline After First Cycle of Chemotherapy. The GCT-SK-003 Phase II Trial
by: Michal Mego, et al.
Published: (2021-11-01)

Complete resolve of primary cardiac sarcoma by chemotherapy: A case report
by: Nasrin Gholami, et al.
Published: (2021-01-01)

The influence of oxazaphosphorine agents on kidney function in rats
by: Łukasz Dobrek, et al.
Published: (2017-07-01)

Rare Primary Malignant Bone Sarcomas
by: Emanuela Palmerini, et al.
Published: (2020-10-01)

Case report of Fanconi syndrome in Wilms tumor
by: Ayu Hutami Syarif, et al.
Published: (2020-07-01)

Systemic Treatment for Advanced and Metastatic Malignant Peripheral Nerve Sheath Tumors—A Sarcoma Reference Center Experience
by: Paweł Sobczuk, et al.
Published: (2020-09-01)

The Enhanced Inhibitory Effect of Different Antitumor Agents in Self-Microemulsifying Drug Delivery Systems on Human Cervical Cancer HeLa Cells
by: Zoltán Ujhelyi, et al.
Published: (2015-07-01)

Primary Pulmonary Synovial Sarcoma during Pregnancy: A Diagnostic and Therapeutic Dilemma
by: Eric M. Harris, et al.
Published: (2014-02-01)

Hind limb ischemic preconditioning induces an anti-inflammatory response by remote organs in rats
by: M.V.P. Souza Filho, et al.
Published: (2009-10-01)

Envolvimento de Ãxido nÃtrico e de canais de potÃssio dependentes de ATP no efeito protetor da amifostina sobre as alteraÃÃes motoras funcionais e inflamatÃrias da Cistite hemorrÃgica induzida por Ifosfamida
by: LÃvia Talita Cajaseiras MourÃo
Published: (2012)

Chloroacétaldéhyde : de l'implication dans les mécanismes physiopathologiques de la néphrotoxicité de l'ifosfamide à la contribution à son effet anticancéreux
by: Knouzy, Burhan
Published: (2009)